Table 6.

Expression level of caspase-3, StAR, and nitric oxide synthase (iNOS) genes in response to different treatments.

Group	Caspase-3	StAR	iNOS
NG	1.13 ± 0.01	2.62 ± 0.05 A	1 ± 0.00
CG	4.31 ± 0.02	0.80 ± 0.02	11.6 ± 0.89
CBG	2.85 ± 0.02	1.76 ± 0.06	5.48 ± 0.6 A
CMG	2.21 ± 0.04	2.23 ± 0.03	8.54 ± 0.2
CMBG	1.64 ± 0.03	2.62 ± 0.04 A	3.9 ± 0.44 A
LSD	0.035	0.060	0.742

Data are expressed as mean of gene expression folds in the six-sampled group (compared to GAPDH) ± SE. All groups have statistically significant (p ≤ 0.05) difference between means, except for groups with the same letter in the same column. The groups are: the normal control group (NG); the Cis group (CG); the group treated with Cis+ beetroot extract (CBG); the group treated with Cis+ mesenchymal stem cells (CMG); and the group treated with Cis+ mesenchymal stem cells + beetroot extract (CMBG).